annual EBITDA:
-$68.59M+$8.04M(+10.49%)Summary
- As of today (August 20, 2025), ABUS annual EBITDA is -$68.59 million, with the most recent change of +$8.04 million (+10.49%) on December 31, 2024.
- During the last 3 years, ABUS annual EBITDA has risen by +$1.30 million (+1.86%).
- ABUS annual EBITDA is now -1384.27% below its all-time high of $5.34 million, reached on December 31, 2006.
Performance
ABUS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$1.92M+$14.62M(+115.15%)Summary
- As of today (August 20, 2025), ABUS quarterly EBITDA is $1.92 million, with the most recent change of +$14.62 million (+115.15%) on June 30, 2025.
- Over the past year, ABUS quarterly EBITDA has increased by +$22.94 million (+109.15%).
- ABUS quarterly EBITDA is now -76.62% below its all-time high of $8.23 million, reached on March 1, 2005.
Performance
ABUS quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$39.52M+$22.94M(+36.73%)Summary
- As of today (August 20, 2025), ABUS TTM EBITDA is -$39.52 million, with the most recent change of +$22.94 million (+36.73%) on June 30, 2025.
- Over the past year, ABUS TTM EBITDA has increased by +$41.47 million (+51.20%).
- ABUS TTM EBITDA is now -579.78% below its all-time high of $8.24 million, reached on March 1, 2007.
Performance
ABUS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ABUS EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10.5% | +109.2% | +51.2% |
3 y3 years | +1.9% | +114.2% | +35.4% |
5 y5 years | +1.0% | +115.4% | +28.9% |
ABUS EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -11.0% | +10.5% | at high | +109.2% | at high | +51.2% |
5 y | 5-year | -24.1% | +10.5% | at high | +109.2% | at high | +51.2% |
alltime | all time | -1384.3% | +10.5% | -76.6% | +108.5% | -579.8% | +51.2% |
ABUS EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $1.92M(-115.2%) | -$39.52M(-36.7%) |
Mar 2025 | - | -$12.70M(+9.3%) | -$62.46M(-8.9%) |
Dec 2024 | -$68.59M(-10.5%) | -$11.62M(-32.2%) | -$68.59M(-11.1%) |
Sep 2024 | - | -$17.14M(-18.5%) | -$77.14M(-4.8%) |
Jun 2024 | - | -$21.02M(+11.6%) | -$80.99M(+3.0%) |
Mar 2024 | - | -$18.83M(-6.6%) | -$78.65M(+2.6%) |
Dec 2023 | -$76.63M(+24.0%) | -$20.16M(-3.9%) | -$76.63M(-0.6%) |
Sep 2023 | - | -$20.98M(+12.3%) | -$77.11M(+5.1%) |
Jun 2023 | - | -$18.68M(+11.1%) | -$73.38M(+7.6%) |
Mar 2023 | - | -$16.81M(-18.6%) | -$68.22M(+10.4%) |
Dec 2022 | -$61.80M(-11.6%) | -$20.65M(+19.7%) | -$61.80M(+0.8%) |
Sep 2022 | - | -$17.25M(+27.6%) | -$61.33M(+0.2%) |
Jun 2022 | - | -$13.52M(+30.2%) | -$61.18M(-6.1%) |
Mar 2022 | - | -$10.38M(-48.6%) | -$65.17M(-6.8%) |
Dec 2021 | -$69.90M(+26.4%) | -$20.18M(+18.0%) | -$69.90M(+6.9%) |
Sep 2021 | - | -$17.11M(-2.3%) | -$65.41M(+4.0%) |
Jun 2021 | - | -$17.51M(+15.9%) | -$62.91M(+8.6%) |
Mar 2021 | - | -$15.10M(-3.7%) | -$57.92M(+4.7%) |
Dec 2020 | -$55.29M(-20.2%) | -$15.69M(+7.4%) | -$55.29M(+5.8%) |
Sep 2020 | - | -$14.61M(+16.7%) | -$52.28M(-6.0%) |
Jun 2020 | - | -$12.52M(+0.3%) | -$55.59M(-12.2%) |
Mar 2020 | - | -$12.48M(-1.6%) | -$63.35M(-8.6%) |
Dec 2019 | -$69.32M(+1.9%) | -$12.68M(-29.3%) | -$69.32M(-3.7%) |
Sep 2019 | - | -$17.92M(-11.6%) | -$71.95M(+0.4%) |
Jun 2019 | - | -$20.28M(+9.9%) | -$71.64M(+2.0%) |
Mar 2019 | - | -$18.45M(+20.5%) | -$70.25M(+3.3%) |
Dec 2018 | -$68.01M(-0.1%) | -$15.31M(-13.0%) | -$67.99M(-4.9%) |
Sep 2018 | - | -$17.61M(-6.8%) | -$71.51M(+8.0%) |
Jun 2018 | - | -$18.89M(+16.7%) | -$66.20M(-0.2%) |
Mar 2018 | - | -$16.18M(-14.1%) | -$66.32M(-2.6%) |
Dec 2017 | -$68.11M(+1.3%) | -$18.83M(+53.0%) | -$68.11M(-0.4%) |
Sep 2017 | - | -$12.30M(-35.3%) | -$68.36M(-4.7%) |
Jun 2017 | - | -$19.00M(+5.8%) | -$71.74M(-5.0%) |
Mar 2017 | - | -$17.96M(-5.9%) | -$75.50M(+4.1%) |
Dec 2016 | -$67.20M(+84.8%) | -$19.08M(+21.7%) | -$72.50M(+24.4%) |
Sep 2016 | - | -$15.68M(-31.1%) | -$58.29M(+2.4%) |
Jun 2016 | - | -$22.77M(+52.2%) | -$56.90M(+29.5%) |
Mar 2016 | - | -$14.96M(+207.1%) | -$43.94M(+20.8%) |
Dec 2015 | -$36.37M(+12.1%) | -$4.87M(-65.9%) | -$36.37M(-13.7%) |
Sep 2015 | - | -$14.29M(+45.7%) | -$42.13M(+22.0%) |
Jun 2015 | - | -$9.81M(+32.8%) | -$34.55M(+1.6%) |
Mar 2015 | - | -$7.39M(-30.5%) | -$34.01M(+4.8%) |
Dec 2014 | -$32.44M(+181.1%) | -$10.63M(+58.5%) | -$32.44M(+34.6%) |
Sep 2014 | - | -$6.71M(-27.6%) | -$24.10M(+15.5%) |
Jun 2014 | - | -$9.27M(+59.2%) | -$20.86M(+43.6%) |
Mar 2014 | - | -$5.82M(+154.3%) | -$14.52M(+25.3%) |
Dec 2013 | -$11.54M(-4.3%) | -$2.29M(-34.0%) | -$11.59M(-22.9%) |
Sep 2013 | - | -$3.47M(+18.3%) | -$15.04M(+14.5%) |
Jun 2013 | - | -$2.94M(+1.7%) | -$13.13M(+4.8%) |
Mar 2013 | - | -$2.89M(-49.7%) | -$12.52M(+4.1%) |
Dec 2012 | -$12.06M | -$5.74M(+266.7%) | -$12.03M(+48.1%) |
Sep 2012 | - | -$1.57M(-32.9%) | -$8.12M(+1.4%) |
Jun 2012 | - | -$2.33M(-2.5%) | -$8.02M(-12.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | -$2.39M(+30.2%) | -$9.18M(-5.0%) |
Dec 2011 | -$9.63M(+78.4%) | -$1.84M(+26.0%) | -$9.67M(-27.4%) |
Sep 2011 | - | -$1.46M(-58.3%) | -$13.32M(+60.0%) |
Jun 2011 | - | -$3.50M(+21.4%) | -$8.33M(+0.0%) |
Mar 2011 | - | -$2.88M(-47.5%) | -$8.33M(-10.3%) |
Dec 2010 | -$5.40M(-17.8%) | -$5.49M(-255.2%) | -$9.28M(+64.1%) |
Sep 2010 | - | $3.54M(-201.2%) | -$5.66M(-49.0%) |
Jun 2010 | - | -$3.49M(-8.8%) | -$11.09M(+22.2%) |
Mar 2010 | - | -$3.83M(+105.4%) | -$9.07M(+37.2%) |
Dec 2009 | -$6.57M(-20.3%) | -$1.87M(-1.9%) | -$6.62M(+20.4%) |
Sep 2009 | - | -$1.90M(+28.8%) | -$5.49M(-5.8%) |
Jun 2009 | - | -$1.48M(+7.5%) | -$5.83M(-37.0%) |
Mar 2009 | - | -$1.37M(+84.6%) | -$9.26M(+7.5%) |
Dec 2008 | -$8.24M(-392.8%) | -$743.60K(-66.8%) | -$8.61M(+11.9%) |
Sep 2008 | - | -$2.24M(-54.2%) | -$7.70M(+103.0%) |
Jun 2008 | - | -$4.90M(+571.9%) | -$3.79M(-374.3%) |
Mar 2008 | - | -$729.00K(-525.3%) | $1.38M(-50.7%) |
Dec 2007 | $2.81M(-47.3%) | $171.40K(-89.7%) | $2.80M(+4.4%) |
Sep 2007 | - | $1.66M(+500.4%) | $2.68M(-47.1%) |
Jun 2007 | - | $277.00K(-59.9%) | $5.07M(-38.5%) |
Mar 2007 | - | $691.00K(+1211.2%) | $8.24M(+50.8%) |
Dec 2006 | $5.34M(+840.5%) | - | - |
Dec 2006 | - | $52.70K(-98.7%) | $5.46M(+98.8%) |
Sep 2006 | - | $4.05M(+17.6%) | $2.75M(-181.9%) |
Jun 2006 | - | $3.44M(-265.4%) | -$3.36M(-66.0%) |
Mar 2006 | - | -$2.08M(-21.8%) | -$9.86M(-2290.1%) |
Dec 2005 | $567.90K(-103.4%) | - | - |
Dec 2005 | - | -$2.66M(+29.4%) | $450.30K(-120.6%) |
Sep 2005 | - | -$2.06M(-32.8%) | -$2.19M(-48.8%) |
Jun 2005 | - | -$3.06M(-137.2%) | -$4.27M(-14.9%) |
Mar 2005 | - | $8.23M(-255.3%) | -$5.02M(-69.8%) |
Dec 2004 | -$16.82M(-34.6%) | - | - |
Dec 2004 | - | -$5.30M(+27.9%) | -$16.63M(-13.8%) |
Sep 2004 | - | -$4.14M(+8.9%) | -$19.30M(-8.2%) |
Jun 2004 | - | -$3.81M(+12.6%) | -$21.01M(+22.1%) |
Mar 2004 | - | -$3.38M(-57.6%) | -$17.21M(+24.5%) |
Dec 2003 | -$25.71M(+16.2%) | - | - |
Dec 2003 | - | -$7.97M(+36.0%) | -$13.83M(+0.2%) |
Sep 2003 | - | -$5.86M(-26.3%) | -$13.80M(-37.6%) |
Dec 2002 | -$22.12M(+72.3%) | - | - |
Dec 2002 | - | -$7.94M(+25.2%) | -$22.12M(+15.1%) |
Sep 2002 | - | -$6.35M(+77.5%) | -$19.23M(+24.4%) |
Jun 2002 | - | -$3.57M(-16.0%) | -$15.45M(+3.2%) |
Mar 2002 | - | -$4.25M(-15.8%) | -$14.97M(+14.1%) |
Dec 2001 | -$12.84M(+31.6%) | - | - |
Dec 2001 | - | -$5.05M(+96.5%) | -$13.12M(+62.6%) |
Sep 2001 | - | -$2.57M(-17.0%) | -$8.07M(+46.8%) |
Jun 2001 | - | -$3.10M(+29.0%) | -$5.50M(+129.0%) |
Mar 2001 | - | -$2.40M | -$2.40M |
Dec 2000 | -$9.76M(+34.9%) | - | - |
Dec 1999 | -$7.23M(-17.4%) | - | - |
Dec 1998 | -$8.75M(+28.1%) | - | - |
Dec 1997 | -$6.83M | - | - |
FAQ
- What is Arbutus Biopharma Corporation annual EBITDA?
- What is the all time high annual EBITDA for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation annual EBITDA year-on-year change?
- What is Arbutus Biopharma Corporation quarterly EBITDA?
- What is the all time high quarterly EBITDA for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation quarterly EBITDA year-on-year change?
- What is Arbutus Biopharma Corporation TTM EBITDA?
- What is the all time high TTM EBITDA for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation TTM EBITDA year-on-year change?
What is Arbutus Biopharma Corporation annual EBITDA?
The current annual EBITDA of ABUS is -$68.59M
What is the all time high annual EBITDA for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high annual EBITDA is $5.34M
What is Arbutus Biopharma Corporation annual EBITDA year-on-year change?
Over the past year, ABUS annual EBITDA has changed by +$8.04M (+10.49%)
What is Arbutus Biopharma Corporation quarterly EBITDA?
The current quarterly EBITDA of ABUS is $1.92M
What is the all time high quarterly EBITDA for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high quarterly EBITDA is $8.23M
What is Arbutus Biopharma Corporation quarterly EBITDA year-on-year change?
Over the past year, ABUS quarterly EBITDA has changed by +$22.94M (+109.15%)
What is Arbutus Biopharma Corporation TTM EBITDA?
The current TTM EBITDA of ABUS is -$39.52M
What is the all time high TTM EBITDA for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high TTM EBITDA is $8.24M
What is Arbutus Biopharma Corporation TTM EBITDA year-on-year change?
Over the past year, ABUS TTM EBITDA has changed by +$41.47M (+51.20%)